Company intelligence / Profile preview

Inato

Paris, France

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Inato operates an AI-powered clinical trial marketplace that connects pharmaceutical sponsors, CROs, and a global network of community-based and academic research sites to accelerate and diversify patient recruitment for clinical trials. Inato reports improved enrollment rates (5x higher) and greater diversity (2x higher) in its enabled clinical trial sites compared to traditional models[2].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

More than half a dozen of the top 30 global pharmaceutical companies[2]Clinical Trials Management Services

Beyond the preview

Go deeper on Inato.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inato.

Explore the full profile